New option available for Alzheimer’s patients as FDA approves expanded drug use
Sentiment Mix
Geography
Expert Signals
Fox News - Latest Headlines
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.
Supported by 1 story
Related Events
Forza Horizon 6 is Steam Deck verified for Valve handheld ahead of release date - Notebookcheck
Product Launch • 5/13/2026
More Cancer Patients Are Taking Ivermectin. Mel Gibson and Joe Rogan Might Be Why. - The New York Times
Uncategorized • 5/13/2026
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials - investor.lilly.com
Uncategorized • 5/13/2026
Psychology Says ’60s and ’70s Kids Didn’t Become Emotionally Strong From Better Parenting. They Learned to Self-Regulate Through Daily Neglect - Indian Defence Review
Uncategorized • 5/13/2026
SpaceX targets May 19 for debut of Starship Version 3, Launch Pad 2 - Spaceflight Now
Product Launch • 5/13/2026
Causality Chain
Preceded By
Led To
New Jersey Gov. Mikie Sherrill announces another NJ Transit World Cup ticket cut days after first reduction
55 causal score
SpaceX targets May 19 for debut of Starship Version 3, Launch Pad 2 - Spaceflight Now
45 causal score
Forza Horizon 6 is Steam Deck verified for Valve handheld ahead of release date - Notebookcheck
45 causal score